CXCR6 and neoplasm: In functional assays with peripheral blood from five untreated patients and ten LEN-TAP–responsive patients (five used for CXCR6 knockdown), coculture for 72 h revealed that LEN-TAP treatment increased tumor-cell BAD expression; CXCR6 silencing attenuated this effect.